At a glance
ClinicalIndex Comparison Record- ✓Age between 1 and 12 years
- ✓Otorrhea (ear drainage) for more than 3 months
- ✕Cholesteatoma
- ✕Known immune deficiency other than IgA or IgG2 deficiency
- ✕Down syndrome
- ✕Craniofacial anomalies
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effectiveness of Sulfamethoxazole-trimethoprim in the Treatment of Chronic Otitis Media
In Brief
A clinical study evaluating Sulfamethoxazole-trimethoprim and Placebo for Chronic Otitis Media. Completed, enrolled 101 participants across 1 site.
Detailed Summary
Chronic suppurative otitis media is one of the most common chronic infections in children worldwide. Symptoms include otorrhea, otalgia and hearing loss. In many countries, it is treated primarily with antibiotics; in other countries such as the Netherlands a surgical approach, such as a tonsillectomy, adenoidectomy, placement or removal of tympanostomy tubes or a tympanomastoidectomy is preferred. There is however, no agreement on the management of this disease. The purpose of this study is to determine the effectiveness of treatment with sulfamethoxazole-trimethoprim for 6-12 weeks in children suffering from chronic otitis media and otorrhea.
Study Details
Timeline
Interventions
18 mg/kg, two times a day